Medivir – funded and ready for further development
Redeye Premium news
2021/02/23
Medivir recently completed a rights issue of approx. SEK 195m before fees. The share is trading slightly above Redeye Bear Case. We've had a chat with analyst Niklas Elmhammer.
Mentioned companies
You need to be a Redeye member to access this content
Become a member to:
Access all our extensive research on 100+ Nordic Tech and Life Science companies
Make smarter investment decisions with the guidance of our experienced analysts
Receive exciting offers to participate in IPO’s and other transactions
By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions